Business Context and Reporting Period
Company: On Assignment, Inc. (Note: Input metadata referenced "Everforth Inc," but the filing text identifies the registrant as On Assignment, Inc.)
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2008
Business Overview: A diversified professional staffing firm operating in four segments: Life Sciences, Healthcare, Physician, and IT and Engineering. The company provides flexible and permanent staffing solutions for specialty skills including laboratory/scientific, healthcare/nursing, physician, medical financial, information technology, and engineering.
Key Financial Metrics (Year Ended Dec 31, 2008)
| Metric | 2008 Value | 2007 Value |
|---|---|---|
| Revenues | $618.1 million | $567.2 million |
| Gross Profit | $199.5 million | $179.5 million |
| Gross Margin | 32.3% | 31.7% |
| Operating Income | $43.5 million | $27.6 million |
| Net Income | $19.0 million | $9.3 million |
| Diluted EPS | $0.53 | $0.26 |
| Cash & Equivalents | $46.3 million | $37.8 million |
| Working Capital | $91.2 million | $79.0 million |
| Long-Term Debt | $125.9 million | $135.9 million |
| Total Assets | $401.9 million | $384.7 million |
Material Changes vs. Prior Period
- Revenue Growth: Consolidated revenues increased 9.0% to $618.1 million. Growth was driven by the Physician (+19.6%) and IT and Engineering (+19.6%) segments, partially offset by a decline in the Life Sciences segment (-3.8%) due to economic conditions and foreign exchange rates.
- Profitability: Net income more than doubled to $19.0 million, driven by revenue growth, a 62 basis point expansion in gross margin, and a $7.0 million decrease in depreciation and amortization expenses.
- Debt Reduction: The company paid down $10.0 million of its term loan facility during 2008, reducing the balance to $125.9 million.
- Segment Performance:
- Life Sciences: Revenues decreased due to a 9.8% drop in the average number of contract professionals and deteriorating foreign exchange rates.
- Healthcare: Revenues increased 3.2%, with Nurse Travel revenues up 4.4%.
- Physician: Revenues increased 19.6% due to a shortage of physicians and higher bill rates.
- IT and Engineering: Revenues increased 19.6%, reflecting a full year of operations (vs. 11 months in 2007) and higher bill rates.
Guidance, Outlook, and Risks
Outlook: Management expects demand for services to remain weak in 2009 due to the challenging economic environment. The company is focusing on controlling operating costs, managing margins, and generating cash. No specific numerical guidance for 2009 revenue or earnings was provided in the text.
Key Risks and Contingencies:
- Economic Conditions: Continued recession and tighter credit markets could adversely affect liquidity and customer spending.
- Debt Covenants: The company must maintain a minimum total leverage ratio. The maximum ratio decreases to 1.25 from 2.0 for the twelve months ended September 30, 2009. Management anticipates needing to prepay debt or seek an amendment to the credit facility to remain compliant.
- Acquisition Earn-outs: Approximately $10.2 million in accrued earn-out payments related to the 2008 performance of VISTA and Oxford are due in April 2009.
- Goodwill Impairment: The company holds $202.8 million in goodwill. While no impairment was recorded in 2008, future declines in market capitalization could trigger impairment charges.
- Self-Insurance: The company is partially self-insured for workers' compensation and medical malpractice, with a liability of approximately $9.8 million.
Investor Verification Checklist
- Debt Covenant Compliance: Verify the company's ability to meet the stricter leverage ratio (1.25) required by September 30, 2009, and confirm if an amendment to the credit facility has been secured.
- Life Sciences Segment Trend: Monitor the Life Sciences segment for continued revenue declines due to the recession and foreign exchange volatility.
- Earn-out Payments: Confirm the timing and amount of the $10.2 million earn-out payment scheduled for April 2009.
- Goodwill Valuation: Assess the risk of future goodwill impairment given the $202.8 million balance and the company's stock price volatility (trading as low as $4.05 in Q4 2008).
- Seasonality: Account for historical demand declines in Q1 and Q4 when evaluating quarterly performance.